相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Appropriate use criteria for amyloid PET: A report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association
Keith A. Johnson et al.
ALZHEIMERS & DEMENTIA (2013)
Disclosure of amyloid imaging results to research participants: Has the time come?
Jennifer H. Lingler et al.
ALZHEIMERS & DEMENTIA (2013)
[18F]NAV4694 shows higher binding and wider dynamic range compared with [11C]PiB in Alzheimer's disease postmortem tissue
Eduardo Zimmer et al.
Alzheimers & Dementia (2013)
Amyloid-beta Imaging with Pittsburgh Compound B and Florbetapir: Comparing Radiotracers and Quantification Methods
Susan M. Landau et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Head-to-Head Comparison of 11C-PiB and 18F-AZD4694 (NAV4694) for β-Amyloid Imaging in Aging and Dementia
Christopher C. Rowe et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
DEMENTIA Disclosure of results to participants in dementia research
Serge Gauthier et al.
NATURE REVIEWS NEUROLOGY (2013)
Amyloid Imaging with PET in Early Alzheimer Disease Diagnosis
Christopher C. Rowe et al.
MEDICAL CLINICS OF NORTH AMERICA (2013)
Amyloid imaging The court of public opinion
Alan J. Lerner
NEUROLOGY (2013)
Using AD biomarker research results for clinical care A survey of ADNI investigators
Melanie B. Shulman et al.
NEUROLOGY (2013)
Clinical applications of neuroimaging in patients with Alzheimer's disease: a review from the Fourth Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012
Jean-Paul Soucy et al.
ALZHEIMERS RESEARCH & THERAPY (2013)
Amyloid PET in clinical practice: Its place in the multidimensional space of Alzheimer's disease
Rik Vandenberghe et al.
NEUROIMAGE-CLINICAL (2013)
Brain Amyloid Imaging
Christopher C. Rowe et al.
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY (2013)
Amyloid-β-Associated Clinical Decline Occurs Only in the Presence of Elevated P-tau
Rahul S. Desikan et al.
ARCHIVES OF NEUROLOGY (2012)
Comparison of 11C-PiB and 18F-florbetaben for Aβ imaging in ageing and Alzheimer's disease
Victor L. Villemagne et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)
Amyloid imaging in Alzheimer's disease: comparison of florbetapir and Pittsburgh compound-B positron emission tomography
David A. Wolk et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2012)
Clinical Validation of 18F-AZD4694, an Amyloid-β-Specific PET Radioligand
Zsolt Cselenyi et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study (vol 11, pg 669, 2012)
C. M. Clark et al.
LANCET NEUROLOGY (2012)
Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease
D. S. Knopman et al.
NEUROLOGY (2012)
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
Randall J. Bateman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study
Christopher M. Clark et al.
LANCET NEUROLOGY (2012)
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Reisa A. Sperling et al.
ALZHEIMERS & DEMENTIA (2011)
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Guy M. McKhann et al.
ALZHEIMERS & DEMENTIA (2011)
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Marilyn S. Albert et al.
ALZHEIMERS & DEMENTIA (2011)
Amyloid Imaging Liberal or Conservative? Let the Data Decide
William J. Jagust
ARCHIVES OF NEUROLOGY (2011)
Association Between In Vivo Fluorine 18-Labeled Flutemetamol Amyloid Positron Emission Tomography Imaging and In Vivo Cerebral Cortical Histopathology
David A. Wolk et al.
ARCHIVES OF NEUROLOGY (2011)
Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD
G. D. Rabinovici et al.
NEUROLOGY (2011)
Addressing the ethical, policy, and social challenges of preclinical Alzheimer disease
Jason Karlawish
NEUROLOGY (2011)
Positron Emission Tomography Radiopharmaceuticals for Imaging Brain Beta-Amyloid
Shankar Vallabhajosula
SEMINARS IN NUCLEAR MEDICINE (2011)
Disclosure of individual genetic data to research participants: the debate reconsidered
Annelien L. Bredenoord et al.
TRENDS IN GENETICS (2011)
Amyloid imaging in the differential diagnosis of dementia: review and potential clinical applications
Robert Laforce et al.
ALZHEIMERS RESEARCH & THERAPY (2011)
Brain Amyloid Imaging
Christopher C. Rowe et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
Amyloid Imaging: Coming to a PET Scanner Near You
William J. Jagust
ANNALS OF NEUROLOGY (2010)
18F-Flutemetamol Amyloid Imaging in Alzheimer Disease and Mild Cognitive Impairment A Phase 2 Trial
Rik Vandenberghe et al.
ANNALS OF NEUROLOGY (2010)
Characterization of AZD4694, a novel fluorinated Aβ plaque neuroimaging PET radioligand
Anders Jureus et al.
JOURNAL OF NEUROCHEMISTRY (2010)
Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging
Christopher C. Rowe et al.
NEUROBIOLOGY OF AGING (2010)
Conversion of amyloid positive and negative MCI to AD over 3 years An 11C-PIB PET study
A. Okello et al.
NEUROLOGY (2009)
The progression of pathology in longitudinally followed patients with Parkinson's disease
Glenda Halliday et al.
ACTA NEUROPATHOLOGICA (2008)
Frequent Amyloid Deposition Without Significant Cognitive Impairment Among the Elderly
Howard Jay Aizenstein et al.
ARCHIVES OF NEUROLOGY (2008)
Imaging of amyloid β in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer:: proof of mechanism
Christopher C. Rowe et al.
LANCET NEUROLOGY (2008)
Communicating the results of clinical research to participants: Attitudes, practices, and future directions
David I. Shalowitz et al.
PLOS MEDICINE (2008)
β-amyloid imaging and memory in non-demented individuals:: evidence for preclinical Alzheimer's disease
Kerryn E. Pike et al.
BRAIN (2007)
Research criteria for the diagnosis of Alzheimers disease: revising the NINCDS-ADRDA criteria
Bruno Dubois et al.
LANCET NEUROLOGY (2007)
Imaging β-amyloid burden in aging and dementia
C. C. Rowe et al.
NEUROLOGY (2007)
[11]PIB in a nondemented population -: Potential antecedent marker of Alzheimer disease
M. A. Mintun et al.
NEUROLOGY (2006)
Neuropathology of older persons without cognitive impairment from two community-based studies
D. A. Bennett et al.
NEUROLOGY (2006)
Offering participants results of a clinical trial: sharing results of a negative study
AH Partridge et al.
LANCET (2005)
Impact of presymptomatic genetic testing for hereditary ataxia and neuromuscular disorders
CO Smith et al.
ARCHIVES OF NEUROLOGY (2004)
Impact of DNA testing for early-onset familial Alzheimer disease and frontotemporal dementia
EJ Steinbart et al.
ARCHIVES OF NEUROLOGY (2001)
Psychological consequences of predictive genetic testing: a systematic review
M Broadstock et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2000)
分享论文
